Read about Endologix
in the news

Embrace the evidence.

2025 News

Endologix Announces that Scott Huennekens Joins Board of Directors

Endologix Announces 1000 patients treated with the DETOUR™ System.

Endologix Appoints Andrew Davis as Chief Commercial Officer

Endologix Announces Leadership Transition